Modified blood factors comprising a low degree of water soluble polymer

Details for Australian Patent Application No. 2009305612 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Turecek, Peter; Siekmann, Juergen; Rottensteiner, Hanspeter

Agent Cullens

Pub. Number AU-A-2009305612

PCT Pub. Number WO2010/045568

Priority 61/106,424 17.10.08 US

Filing date 16 October 2009

Wipo publication date 22 April 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/045568 Priority application(s): WO2010/045568

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305617-Tumor vaccine

2009305602-Method of determining a phosphorus binder dosage for a dialysis patient